Marshall Wace, founded in 1997, is a leading global alternatives investment manager specializing in long/short equity. The firm is one of the world’s largest alternative asset managers, managing in excess of $33 B with over 250 employees working in London, New York, and Hong Kong.
Marshall Wace’s $3bn Global Healthcare long/short equity strategy invests in all sub-sectors of healthcare, including biotech, pharma, medtech, hospitals, managed care and other healthcare services. The team consists of a portfolio manager and three analysts with experiences that span scientific and medical research, business development and operations, equity research and consulting. The portfolio manager has a multi-year, long term track record of generating positive returns for institutional investors. The team conducts deep fundamental research that includes identifying shifts in market trends, analyzing scientific/clinical data, modeling key business and financial drivers for various subsectors, building financial models, and meeting with management teams.
Therapeutics Analyst Description
The Global Healthcare team is seeking to hire an analyst as a key team member supporting all aspects of its fundamental research process for therapeutic names. This analyst will be responsible for the therapeutic sectors with a focus on small to mid-cap biotech stocks. Candidates should have the following qualifications and characteristics: